Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aquestive Therapeutics Inc (NQ: AQST )

5.670 +0.050 (+0.89%)
Official Closing Price Updated: 7:55 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aquestive Therapeutics Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
54 Biggest Movers From Yesterday
Gainers Peck Co. Inc. (NASDAQ: PECK) shares climbed 235% to close at $17.05 on Thursday. Edesa Biotech, Inc. (NASDAQ: EDSA) ... 
Tags LAND DMRC Market News
From Benzinga
35 Stocks Moving In Thursday's Mid-Day Session
Gainers Peck Co. Inc. (NASDAQ: PECK) shares rose 234% to $17.00. Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 119% to ... 
Tags Intraday Update Trading Ideas PSNL
From Benzinga
Analysts Predict 16% Upside For The Holdings of UWM
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Aquestive Therapeutics to Present at Two Upcoming Investor Conferences
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that meet patients' unmet needs and solve therapeutic... 
From PR Newswire
Aquestive Therapeutics Completes Enrollment in Libervant™ (diazepam buccal film) Crossover Study
- Files first section of rolling New Drug Application (NDA) submission with U.S. Food and Drug Administration (FDA) 
From PR Newswire
66 Biggest Movers From Yesterday
Gainers Mirati Therapeutics, Inc. (NASDAQ: MRTX) gained 31.6 percent to close at $89.20 on Monday in sympathy with Amgen after ... 
Tags MYOV BSGM CLDX
From Benzinga
The Daily Biotech Pulse: Inovio's Partner Scales Back R&D Collaboration, Genmab Seeks Nasdaq Listing, Bayer Gets Breakthrough Therapy Designation
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags ALKS MIST ZIOP
From Benzinga
50 Biggest Movers From Friday
Gainers Outlook Therapeutics, Inc. (NASDAQ: OTLK) shares gained 42.4 percent to close at $2.79 on Friday. Avianca Holdings S.A. ... 
Tags PIRS IBN MYT
From Benzinga
30 Stocks Moving In Friday's Mid-Day Session
Gainers Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) shares climbed 32.9 percent to $0.835. Roth Capital assumed Cyclacel ... 
Tags DFFN Movers & Shakers Markets
From Benzinga
50 Biggest Movers From Yesterday
Gainers JMU Ltd- ADR (NASDAQ: JMU) shares jumped 61.2 percent to close at $1.95 after the company acquired Unicorn Investment ... 
Tags CR PPDF ONCS
From Benzinga
Aquestive Therapeutics to Present at Two Upcoming Investor Conferences
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that meet patients' unmet needs and solve therapeutic... 
From PR Newswire
The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stock To Debut
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags RTRX PHAS OPNT
From Benzinga
95 Biggest Movers From Yesterday
Gainers Corindus Vascular Robotics, Inc. (NYSE: CVRS) climbed 35.71 percent to close at $2.85 on Wednesday following Q1 ... 
Tags AVRO CTSO Market News
From Benzinga
75 Stocks Moving In Wednesday's Mid-Day Session
Gainers Akorn, Inc. (NASDAQ: AKRX) shares rose 35 percent to $4.79. Akorn shares surged Tuesday after the company reported ... 
Tags MYGN LYFT SGMS
From Benzinga
The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags DSNKY AXGN EYPT
From Benzinga
Aquestive Therapeutics Reports First Quarter 2019 Financial Results and Recent Business Highlights
- U.S. launch of Sympazan® (clobazam) Oral Film progressing to plan 
From PR Newswire
IntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for Tadalafil
IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it has entered into a definitive worldwide agreement with Aquestive Therapeutics, Inc.... 
From GlobeNewswire News Releases
Aquestive Therapeutics Announces Daniel Barber Named to Chief Operating Officer
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced the... 
From PR Newswire
Aquestive Therapeutics Enters Oversold Territory (AQST)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Aquestive Therapeutics to Announce First Quarter 2019 Financial Results and Recent Business Highlights on May 8, 2019
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that it... 
From PR Newswire
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application for Riluzole Oral Film for Treatment of ALS
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that the... 
From PR Newswire
Market Trends Toward New Normal in Smartsheet, Spok, TPG RE Finance Trust, DSP Group, Adaptimmune Therapeutics, and Aquestive Therapeutics — Emerging Consolidated Expectations, Analyst Ratings
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Smartsheet Inc. (NYSE:SMAR),... 
From GlobeNewswire News Releases
62 Biggest Movers From Friday
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 31.94 percent to close at $0.7125 on Friday after the company ... 
Tags SAIC DCAR CPAH
From Benzinga
Aquestive Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that... 
From PR Newswire
71 Biggest Movers From Yesterday
Gainers Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 368.21 percent to close at $7.07 on Thursday after the company received ... 
Tags Yesterday's Gainers FET Losers
From Benzinga
56 Stocks Moving In Thursday's Mid-Day Session
Gainers Atossa Genetics Inc (NASDAQ: ATOS) shares jumped 242.4 percent to $5.17 after the company received FDA approval of oral ... 
Tags Market News ICON KALV
From Benzinga
The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags ABT Market News PDLI
From Benzinga
Aquestive Therapeutics, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights
- Secured U.S. Food and Drug Administration (FDA) approval and launched the first proprietary commercial product in its epilepsy franchise, SYMPAZAN™ (clobazam) Oral Film 
From PR Newswire
Aquestive Therapeutics to Present at Oppenheimer's 29th Annual Healthcare Conference
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that... 
From PR Newswire
Analysts Predict 26% Gains Ahead For IBB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.